Advance Search
YU Shuyan, YANG Yi, HU Ting, CAO Yanpei. Expression of interleukin-13 receptor α2 in cancer cells of colorectal cancer patients with liver metastasis and its relationship with myeloid-derived suppressor cells[J]. Journal of Clinical Medicine in Practice, 2020, 24(23): 65-69. DOI: 10.7619/jcmp.202023021
Citation: YU Shuyan, YANG Yi, HU Ting, CAO Yanpei. Expression of interleukin-13 receptor α2 in cancer cells of colorectal cancer patients with liver metastasis and its relationship with myeloid-derived suppressor cells[J]. Journal of Clinical Medicine in Practice, 2020, 24(23): 65-69. DOI: 10.7619/jcmp.202023021
shu

Expression of interleukin-13 receptor α2 in cancer cells of colorectal cancer patients with liver metastasis and its relationship with myeloid-derived suppressor cells

  • 1. Department of General Surgery, 2. Nursing Department, Huashan Hospital Affiliated to Fudan University, Shanghai, 200041

More Information
  • Received Date: October 14, 2020
  • Available Online: December 20, 2020
    Graphical Abstract
    • Abstract
  • Objective To investigate the expression of interleukin-13 receptor α2(IL-13Rα2)in cells of colorectal cancer patients with liver metastasis and its relationship with myeloid-derived suppressor cells(MDSCs). Methods Paraffin sections of 68 patients with colorectal cancer surgery in Huashan Hospital Affiliated to Fudan University from 2000 to 2013 were retrospectively analyzed. The expression of IL-13Rα2 was observed after routine immunostaining. Anti-CD11B antibody and anti-CD33 antibody were used for double staining. Fluorescent antibody, goat anti-rabbit immunoglobulin(H+L)antibody and goat anti-mouse immunoglobulin(H+L)antibody were used to display CD33. Three pathologists independently evaluated IL-13Rα2 stained slides in a double-blind manner. Results The positive rate of IL-13Rα2 in colorectal cancer patients with liver metastasis was the highest(90.8%), followed by brain metastasis(65.0%), primary lesions(60.0%), and other metastases(53.0%), and there were significant differences(P<0.05). There was a linear correlation between the expression of IL-13Rα2 and the number of MDSCs in cases with liver metastasis(r=0.740, P<0.05). The average survival time of 48 patients with distant metastasis was(12.6±5.2)months. Conclusion The increased level of IL-13Rα2 suggests that the prognosis of colorectal cancer patients with distant metastasis is poor, and it is speculated that IL-13Rα2 can induce proliferation of MDSCs and promote liver metastasis by regulating colorectal cancer cells.
    • FullText(HTML)
    • References (32)
  • FERLAY J, SHIN H R, BRAY F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12): 2893-2917.
    FONG Y, COHEN A M, FORTNER J G, et al. Liver resection for colorectal metastases[J]. J Clin Oncol, 1997, 15(3): 938-946.
    ABDALLA E K, RIBERO D, PAWLIK T M, et al. Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival[J]. J Gastrointest Surg, 2007, 11(1): 66-72.
    LEPORRIER J, MAUREL J, CHICHE L, et al. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer[J]. Br J Surg, 2006, 93(4): 465-474.
    RUERS T J, WIERING B, VAN DER SIJP J R, et al. Improved selection of patients for hepatic surgery of colorectal liver metastases with(18)F-FDG PET: a randomized study[J]. J Nucl Med, 2009, 50(7): 1036-1041.
    WYNN T A. IL-13 effector functions[J]. Annu Rev Immunol, 2003, 21: 425-456.
    FUJISAWA T, JOSHI B, NAKAJIMA A, et al. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis[J]. Cancer Res, 2009, 69(22): 8678-8685.
    MANDAL D, LEVINE A D. Elevated IL-13Ralpha2 in intestinal epithelial cells from ulcerative colitis or colorectal cancer initiates MAPK pathway[J]. Inflamm Bowel Dis, 2010, 16(5): 753-764.
    HUSAIN S R, JOSHI B H, PURI R K. Interleukin-13 receptor as a unique target for anti-glioblastoma therapy[J]. Int J Cancer, 2001, 92(2): 168-175.
    OSTRAND-ROSENBERG S. Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity[J]. Cancer Immunol Immunother, 2010, 59(10): 1593-1600.
    GABRILOVICH D. Mechanisms and functional significance of tumour-induced dendritic-cell defects[J]. Nat Rev Immunol, 2004, 4(12): 941-952.
    OSTRAND-ROSENBERG S, SINHA P. Myeloid-derived suppressor cells: linking inflammation and cancer[J]. J Immunol, 2009, 182(8): 4499-4506.
    SICA A, BRONTE V. Altered macrophage differentiation and immune dysfunction in tumor development[J]. J Clin Invest, 2007, 117(5): 1155-1166.
    GABITASS R F, ANNELS N E, STOCKEN D D, et al. Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13[J]. Cancer Immunol Immunother, 2011, 60(10): 1419-1430.
    HALL B, NAKASHIMA H, SUN Z J, et al. Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling[J]. J Transl Med, 2013, 11: 45.
    JEMAL A, BRAY F, CENTER M M, et al. Global cancer statistics[J]. CA: A Cancer J Clin, 2011, 61(2): 69-90.
    SIMMONDS P C, PRIMROSE J N, COLQUITT J L, et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies[J]. Br J Cancer, 2006, 94(7): 982-999.
    CHIARAMONTE M G, MENTINK-KANE M, JACOBSON B A, et al. Regulation and function of the interleukin 13 receptor α 2 during a T helper cell type 2–dominant immune response[J]. J Exp Med, 2003, 197(6): 687-701.
    FICHTNER-FEIGL S, STROBER W, KAWAKAMI K, et al. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis[J]. Nat Med, 2006, 12(1): 99-106.
    JOSHI B H, PLAUTZ G E, PURI R K. Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas[J]. Cancer Res, 2000, 60(5): 1168-1172.
    KAWAKAMI M, KAWAKAMI K, KASPERBAUER J L, et al. Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker[J]. Clin Cancer Res, 2003, 9(17): 6381-6388.
    PURI R K, LELAND P, OBIRI N I, et al. Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A(PE38QQR)[J]. Blood, 1996, 87(10): 4333-4339.
    MINN A J, GUPTA G P, SIEGEL P M, et al. Genes that mediate breast cancer metastasis to lung[J]. Nature, 2005, 436(7050): 518-24.
    FUJISAWA T, JOSHI B, NAKAJIMA A, et al. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis[J]. Cancer Res, 2009, 69(22): 8678-8685.
    BARDERAS R, BARTOLOMÉR A, FERNANDEZ-ACEÑERO M J, et al. High expression of IL-13 receptor α2 in colorectal cancer is associated with invasion, liver metastasis, and poor prognosis[J]. Cancer Res, 2012, 72(11): 2780-2790.
    APRILE G, DE MAGLIO G, MENIS J, et al. HER-2 expression in brain metastases from colorectal cancer and corresponding primary tumors: a case cohort series[J]. Int J Mol Sci, 2013, 14(2): 2370-2387.
    RODRIGUEZ P C, ZEA A H, DESALVO J, et al. L-arginine consumption by macrophages modulates the expression of CD3 Zeta chain in T lymphocytes[J]. J Immunol, 2003, 171(3): 1232-1239.
    RODRIGUEZ P C, QUICENO D G, ZABALETA J, et al. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses[J]. Cancer Res, 2004, 64(16): 5839-5849.
    NAGARAJ S, GUPTA K, PISAREV V, et al. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer[J]. Nat Med, 2007, 13(7): 828-835.
    HOECHST B, ORMANDY L A, BALLMAIER M, et al. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells[J]. Gastroenterology, 2008, 135(1): 234-243.
    KO J S, ZEA A H, RINI B I, et al. Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients[J]. Clin Cancer Res, 2009, 15(6): 2148-2157.
    HALL B, NAKASHIMA H, SUN Z J, et al. Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling[J]. J Transl Med, 2013, 11: 45-53.
    • Related Articles

  • Related Articles

    [1]QIU Qian, XUE Tongmin, HUANG Mengyao, WEI Binkai, LU Dan. Research progress of surgical hemostatic methods for placenta previa with placenta accreta in cesarean section[J]. Journal of Clinical Medicine in Practice, 2022, 26(23): 143-148. DOI: 10.7619/jcmp.20221677
    [2]LIU Yangyang, YOU Yan, QIN Aiping, MA Min. A case analysis of fetal limb-body wall syndrome[J]. Journal of Clinical Medicine in Practice, 2022, 26(4): 127-129. DOI: 10.7619/jcmp.20212343
    [3]SUN Jing, PANG Ying, CHEN Xiang, TIAN Hua, QUAN Xiaofang, REN Lingling, JIA Baoxia, LYU Pin. Effect of pull-up cervical suture on hemostasis in patients with dangerous placenta previa[J]. Journal of Clinical Medicine in Practice, 2020, 24(15): 76-78,82. DOI: 10.7619/jcmp.202015021
    [4]DU Nan, YAO Yanjiao, XIE Yanyan, LU Dan. Application of “one-stop” dual interventional technique in pernicious placenta previa[J]. Journal of Clinical Medicine in Practice, 2020, 24(1): 102-104. DOI: 10.7619/jcmp.202001026
    [5]MA Xiaojing, YU Wuxia. Effect of magnetic resonance imaging in diagnosisof placenta previa complicating with placenta implantation[J]. Journal of Clinical Medicine in Practice, 2019, 23(24): 14-17. DOI: 10.7619/jcmp.201924005
    [6]SUN Baolin, BAI Yufang, ZHAO Shengzhu. Perioperative nursing experience for patients with pernicious placenta previa[J]. Journal of Clinical Medicine in Practice, 2018, (2): 130-132. DOI: 10.7619/jcmp.201802040
    [7]LI Wei. Analysis of color Doppler ultrasonography and two-dimensional ultrasonography in the diagnosis of cicatricial uterus complicated with placenta previa[J]. Journal of Clinical Medicine in Practice, 2018, (1): 98-100. DOI: 10.7619/jcmp.201801030
    [8]LI Qin, DENG Xuedong, WANG Zhongyang, LU Bing, ZHANG Lili, SHEN Jianqiu, BIAN Min. Value of transabdominal combined with transperineal ultrasound in diagnosis of pernicious placenta previa complicated with placenta implantation[J]. Journal of Clinical Medicine in Practice, 2016, (11): 83-86. DOI: 10.7619/jcmp.201611024
    [9]QING Ying. Application of uterine vessels loop ligature with tourniquet as hemostatic agents in caesarean section for placenta previa[J]. Journal of Clinical Medicine in Practice, 2015, (Z1): 139-140.
    [10]LIU Shuqin. Hemostasis effects of intrauterine gauze ribbon packing in the treatment of bleeding in central placenta previa caesarean section operation[J]. Journal of Clinical Medicine in Practice, 2014, (3): 56-58. DOI: 10.7619/jcmp.201403018

  • Cited by

    Periodical cited type(25)

    1. 蒋佳玲，杨童玲. 1例持续性肺动脉高压合并母体HIV感染新生儿的多元个性化护理. 全科护理. 2024(24): 4742-4746 .
    2. 王风洋. 不同浓度一氧化氮联合米力农对新生儿胎粪吸入性肺炎持续肺动脉高压患儿肺氧合功能及炎性反应的影响. 中国妇幼保健. 2023(01): 48-51 .
    3. 陈顺何，李霜洁，杨夏敏. 米力农和西地那非分别联合机械通气治疗新生儿PPHN疗效评价. 中国处方药. 2023(01): 103-106 .
    4. 郑碧娟. 米力农联合酚妥拉明对新生儿肺动脉持续高压患儿动脉血气及血清炎症指标的影响. 淮海医药. 2023(04): 407-409 .
    5. 吴旭婷，凌超民，陈晓琳. 呼吸训练器联合床旁端坐法对ICU机械通气患者膈肌功能的影响. 哈尔滨医药. 2022(06): 31-33 .
    6. 刘倩，张爱梅. 高频振荡通气下西地那非联合米力农治疗新生儿持续肺动脉高压的疗效观察. 当代医学. 2021(02): 83-86 .
    7. 谭乐. 米力农联合高频通气对新生儿持续性肺动脉高压患儿血气指标的影响. 当代医学. 2021(03): 138-139 .
    8. 李明耀，陈文滨. 西地那非联合米力农治疗新生儿持续肺动脉高压疗效及对细胞因子表达的影响. 中国处方药. 2021(02): 73-74 .
    9. 王会影，范雪爱，田艳茹，李正川，靳雅玲，刘欣. 一氧化氮吸入联合高频振荡通气治疗新生儿持续性肺动脉高压的效果分析. 中国病案. 2021(01): 96-100 .
    10. 陈尊，刘芳，邓健. 小剂量多巴胺和多巴酚丁胺静脉滴注联合高频振荡通气治疗新生儿持续肺动脉高压的临床疗效研究. 实用心脑肺血管病杂志. 2021(03): 101-105 .
    11. 柳慧. 米力农与硫酸镁单一及联合用药治疗新生儿肺动脉高压的疗效对比. 现代诊断与治疗. 2021(03): 362-363 .
    12. 李海志，王丹，李特. 米力农治疗新生儿持续性肺动脉高压有效性的系统评价. 中国医院用药评价与分析. 2021(03): 324-328 .
    13. 刘欣，何海英，刘利军，吴海焕. 米力农治疗新生儿持续性肺动脉高压的Meta分析. 中国卫生标准管理. 2021(18): 100-103 .
    14. 全守东，于亚杰，梁志霞. 一氧化氮吸入联合米力农治疗新生儿持续性肺动脉高压的疗效及对血流动力学、血小板聚集功能的影响. 临床和实验医学杂志. 2020(01): 89-91 .
    15. 黄杰，乾艾娜，甘斌，何源，魏贤. 米力农对新生儿持续肺动脉高压的治疗作用评价. 中国继续医学教育. 2020(05): 131-133 .
    16. 齐丽娟. 强化护理动脉血气技术对临床诊断治疗的意义探讨. 人人健康. 2020(10): 169 .
    17. 陈波，白波，李广洪，黄学良，罗惠玲，黄惠仪. 波生坦治疗新生儿缺氧性肺动脉高压的临床观察. 中国药房. 2020(10): 1247-1252 .
    18. 蔡云. 高频振荡通气联合多巴胺治疗PPHN的效果及对氧合指数、D-D水平的影响. 数理医药学杂志. 2020(06): 857-859 .
    19. 曹玉晖，南彦武，贾永锋. 米力农和硫酸镁治疗新生儿肺动脉高压的临床效果比较. 临床医学研究与实践. 2020(29): 92-94 .
    20. 曹祎明，胡玉莲，于凤琴，王广州. 米力农联合高频震荡通气治疗新生儿缺氧性肺动脉高压的疗效及对HIF-1α ET-1 HO-1水平的影响. 安徽医学. 2020(11): 1299-1302 .
    21. 吴丹，刘颖，董世霄，翁景文，张金晶，王晓娇，黑明燕，王亚娟. 早产儿与足月儿新生儿持续性肺动脉高压临床资料的对比分析. 北京医学. 2020(12): 1201-1205 .
    22. 马兵. 分析米力农对新生儿持续性肺动脉高压的临床治疗效果. 世界最新医学信息文摘. 2019(25): 54 .
    23. 李华，李泉泉，刘本玉. 米力农对新生儿持续肺动脉高压的疗效. 中国卫生标准管理. 2019(10): 40-42 .
    24. 王彦波，李敏，金宝，王云，陈洋，吴杰斌，刘枭，周彬. 机械通气联合西地那非对新生儿持续性肺动脉高压血流动力学及细胞因子的影响. 中华临床医师杂志(电子版). 2019(09): 659-663 .
    25. 张进军，王瑛，李海欣，张琳，王淮燕. 新生儿窒息复苏后发生持续性肺动脉高压的相关因素及预防措施. 实用临床医药杂志. 2019(20): 32-34+38 . 本站查看

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (376) PDF downloads (18) Cited by(25)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return